Approach

Collaborate. Collaborate. And collaborate some more.

We reach out to hospitals, academic institutions and primary care organizations to get the clearest possible understanding of the diabetes care process and the needs of patients.

Clinically relevant and regulatory compliant

Patient needs

We collaborate with Astrid Lindgrens Children’s Hospital at Karolinska University Hospital in Sweden so the needs of insulin-dependent children are met by the new digital care flow used by the clinic.

Clinical trial

We have a two-year clinical study running at nine of Medicover’s Polish clinics which assesses different health outcomes between adults with Type 2 diabetes who use the Triabetes smartphone app and those who do not.

ISO 13485

We hold an ISO 13485 certificate from the British Standards Institution (BSI) which means we have the rigorous quality management system required for the design and distribution of medical devices.

Primary care clinics

We work with the managed care group Medicover in Poland and their feedback about how TriabetesClinic is used in day-to-day clinical practice is invaluable.

Data integrity

We carefully handle all patient data. Since our software tracks parameters to moderate a disease, we follow strict medical device regulations.

CE mark

We comply with the European Medical Device Directive (93/42 EEC) so our apps can proudly display the CE mark ‘stamp of approval’. When we are cleared for the USA, we will let you know.

Polish clinical study supervised by the Medical University of Warsaw and Karolinska Institutet

“We found that it is clinically worthwhile to use the Triabetes app combined with the TriabetesClinic service to support the patients to improve metabolic control and lower their HbA1c values.”

 

“Our interim analysis after six months showed that apps are a viable way to help control Type 2 diabetes when the patient shares live data with their doctor or nurse, who in turn use a web-based triage service to monitor, coach and suggest treatment strategies.”

 

Kerstin Brismar, Professor of Diabetes Research at Karolinska Institutet in Stockholm, speaking in October 2014. Read more

Clinical Advisory Board

Convened to give advice on incorporating scientific and medical perspectives in our strategic direction, the members of the Clinical Advisory Board are:

Professor Per-Olof Berggren Ph.D.

Member of the Rolf Luft Research Centre for Diabetes. Professor of Experimental Endocrinology at Karolinska Institutet.

Professor Sebastiano Filetti

Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Italy.

Dr. Marianna Maranghi Ph.D.

Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Italy.